| All patients (n = 378) | Transfused (n = 168) | Non-transfused (n = 210) | P valued |
---|---|---|---|---|
No. of patients with nosocomial infections | 158 (41.8) | 91 (54.2) | 67 (31.9) | <  0.001a |
 No. of patients with MDR-NI | 24 (15.2) | 16 (17.6) | 8 (11.9) | n.s.a |
No. of nosocomial infections | 210 | 133 | 77 | – |
 No. of MDR-NI | 28 (13.3) | 20 (15.0) | 8 (10.4) | n.s.a |
 No. of NI per patient | 0.56 (± 0.78) | 0.79 (± 0.92) | 0.37 (± 0.57) | <  0.001c |
No. of nosocomial infections by site/type | ||||
 Lower respiratory tract infection | 72 (19.0) | 48 (28.7) | 24 (11.4) | <  0.001a |
  Ventilator-associated pneumonia | 24 (6.4) | 22 (13.1) | 2 (1.0) | <  0.001a |
  Tracheobronchitis | 48 (12.7) | 26 (15.5) | 22 (10.5) | n.s.a |
 Urinary tract infection | 61 (16.1) | 32 (19.0) | 29 (13.8) | n.s.a |
 Gastroenteritis | 32 (8.5) | 20 (11.9) | 12 (5.7) | n.s.a |
  Clostridium-associated infection | 29 (7.7) | 17 (10.1) | 12 (5.7) |  |
  Norovirus infection | 3 (0.8) | 3 (1.8) | 0 (0.0) |  |
 Decubitus infection | 7 (1.9) | 5 (3.0) | 2 (1.0) | n.s.b |
 Catheter-related BSI | 22 (5.8) | 13 (7.7) | 9 (4.3) | n.s.a |
 Other | 16 (4.2) | 15 (8.9) | 1 (0.5) | <  0.001b |
  Biliary tract infection | 1 | 1 | 0 |  |
  Lung abscess and empyema | 1 | 1 | 0 |  |
  Endocarditis | 1 | 1 | 0 |  |
  Laboratory-confirmed BSI | 3 | 3 | 0 |  |
  Mediastinitis | 1 | 1 | 0 |  |
  Peritonitis (primary/secondary) | 3 | 3 | 0 |  |
  Skin and soft tissue infection | 1 | 1 | 0 |  |
  Surgical site infection | 5 | 4 | 1 |  |
No. of isolated pathogens | 241 | 153 | 88 | – |
 No. of isolated MDR pathogens | 30 (12.4) | 21 (13.7) | 9 (10.2) | n.s.a |
Time to 1st nosocomial infection (days) | 14.7 (± 11.4) | 16.4 (± 12.3) | 12.5 (± 9.7) | 0.030c |